|
Federal Register
Notices
> Manufacturers 2008 >
Alltech Associates Inc.
FR Doc E8-22875[Federal Register: September 29, 2008 (Volume 73, Number 189)]
[Notices] [Page 56613-56614] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29se08-110]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 19, 2008 and published in the Federal Register on March
28, 2008 (73 FR 16719), Alltech Associates Inc., 2051 Waukegan Road, Deerfield,
Illinois 60015, made application to the Drug Enforcement Administration (DEA) to
be registered as
[[Page 56614]]
a bulk manufacturer of the basic classes of controlled substances listed in
schedules I and II:
|
Drug
|
Schedule
|
|
Methcathinone (1237)
|
I
|
|
N-Ethylamphetamine (1475)
|
I
|
|
N,N-Dimethylamphetamine (1480)
|
I
|
|
4-Methylaminorex (cis isomer) (1590)
|
I
|
|
Alpha-ethyltryptamine (7249)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Mescaline (7381)
|
I
|
|
4-Bromo-2,5-dimethoxyamphetamine (7391)
|
I
|
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
|
4-Methyl-2,5-dimethoxyamphetamine (7395)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
2,5-Dimethoxy-4-ethylamphetamine (7399)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (MDMA) (7405)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Alpha-methyltryptamine (7432)
|
I
|
|
Bufotenine (7433)
|
I
|
|
Diethyltryptamine (7434)
|
I
|
|
Dimethyltryptamine (7435)
|
I
|
|
Psilocybin (7437)
|
I
|
|
Psilocyn (7438)
|
I
|
|
5-Methoxy-N,N-diisopropyltryptamine (7439)
|
I
|
|
N-Ethyl-1-phenylcyclohexylamine (7455)
|
I
|
|
1-(1-Phenylcyclohexyl)pyrrolidine (7458)
|
I
|
|
1-Phenylcyclohexylamine (7460)
|
I
|
|
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)
|
I
|
|
Normorphine (9313)
|
I
|
|
Methamphetamine (1105)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Phenylacetone (8501)
|
II
|
|
1-Piperidinocyclohexanecarbonitrile (8603)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Dihydromorphine (9145)
|
II
|
|
Ecgonine (9180)
|
II
|
|
Meperidine intermediate-B (9233)
|
II
|
|
Noroxymorphone (9668)
|
II
|
The company plans to manufacture high purity drug standards used for
analytical applications only in clinical, toxicological, and forensic
laboratories.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Alltech Associates,
Inc. to manufacture the listed basic classes of controlled substances is
consistent with the public interest at this time. DEA has investigated Alltech
Associates Inc. to ensure that the company's registration is consistent with the
public interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and history.
Therefore, pursuant to 21
U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-22875 Filed 9-26-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
